Peers of Cytek Biosciences Inc (CTKB)
Side-by-side comparison
Health Care · Life Sciences Tools & Services
Market capitalization divided by trailing twelve-month free cash flow.
Latest P/FCF Ratio
-58.21x
As of Oct 9, 2026
Beyond P/FCF Ratio, the valuation view includes forward multiples, EV ratios, cash flow yields, and multi-year chart history for further research.
| Date | P/FCF Ratio |
|---|---|
| Oct 9, 2026 | -58.21x |
| Oct 8, 2026 | -57.25x |
| Oct 7, 2026 | -57.03x |
| Oct 6, 2026 | -57.46x |
| Oct 5, 2026 | -65.04x |
| Oct 2, 2026 | -62.70x |
| Oct 1, 2026 | -62.05x |
| Sep 30, 2026 | -63.66x |
P/FCF Ratio = Market Capitalization / Free Cash Flow (TTM)
P/FCF focuses on actual cash generation rather than accounting profit.
Read the general P/FCF Ratio definition, formula, and analyst usage guide.
P/FCF Ratio guideInformational research only; not personalized advice. Values reflect the latest available data on Chartloom and may differ from other sources.
Side-by-side comparison